Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
71.72
-0.28 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
71.75
0.03%
After-hours: Aug 15, 2025, 04:54 PM EDT
Corcept Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 102.75M | 89.82M | 127.67M | 137.29M | 128.59M | 149.75M | 135.55M | 111.8M | 172.38M | 465.06M | 436.62M | 50.24M | 381.98M | 61.86M | 335.81M | 94.69M | 95.43M | 52.38M |
Short-Term Investments | 239.48M | 232.94M | 255.67M | 243.05M | 344.57M | 261.01M | 232.67M | 243.43M | 190.88M | 165.12M | 365.34M | 346.02M | 334.74M | 283.67M | 145.92M | 266.64M | 274.55M | 320.58M |
Long-Term Investments | 172.78M | n/a | 219.83M | 167.31M | 19.32M | 40.28M | 57.18M | 59.62M | n/a | n/a | 4.95M | 4.89M | 11.89M | 22.57M | 112.28M | 133.84M | 101.66M | 81.83M |
Other Long-Term Assets | 16.29M | 255.82M | 10.19M | 14.74M | 15.39M | 14.23M | 14.79M | 15.29M | 13.18M | 21.09M | 17.17M | 16.11M | 6.16M | 16.08M | 14.4M | 17.77M | 18.87M | 20.41M |
Receivables | 64.57M | 61.82M | 53.98M | 59.72M | 53.84M | 63.52M | 41.12M | 34.63M | 32.55M | 47.66M | 31.06M | 29.41M | 28.16M | 27.18M | 27.63M | 26.51M | 27.62M | 22.2M |
Inventory | 12.28M | 14.37M | 12.41M | 8.05M | 8.35M | 7.19M | 7.73M | 7.51M | 6.92M | 16.57M | 17.03M | 6.05M | 17.41M | 5.08M | 17.95M | 4.99M | 4.67M | 4.95M |
Other Current Assets | 11.87M | 39.55M | 10.57M | 10.16M | 20.36M | 2M | 41.56M | 34.16M | 29.86M | 29.87M | 30.42M | 900K | 1.7M | 1M | 1.4M | 9.07M | 9M | 9.52M |
Total Current Assets | 443.11M | 438.5M | 471.6M | 466.98M | 560.85M | 503.37M | 458.64M | 431.53M | 432.59M | 528.18M | 498.71M | 452.4M | 427.56M | 388.22M | 381.39M | 401.9M | 411.27M | 409.62M |
Property-Plant & Equipment | 7.31M | 7.69M | 8.01M | 8.43M | 7.16M | 188K | 315K | 480K | 648K | 575K | 1.14M | 2.51M | 2.26M | 3.54M | 514K | 2.25M | 2.94M | 3.5M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -112.28M | n/a | n/a | n/a |
Total Long-Term Assets | 358.61M | 407.95M | 368.95M | 317.28M | 153.71M | 152.57M | 162.88M | 162.5M | 92.04M | 89.67M | 84.72M | 80.85M | 68.81M | 79.9M | 42.37M | 183.5M | 157.21M | 142.77M |
Total Assets | 801.72M | 846.46M | 840.55M | 784.26M | 714.55M | 655.93M | 621.52M | 594.02M | 524.63M | 617.85M | 583.43M | 533.25M | 496.36M | 468.12M | 423.76M | 585.4M | 568.48M | 552.4M |
Account Payables | 23.52M | 27.95M | 15.38M | 18.58M | 19.48M | 12.56M | 17.4M | 16.71M | 7.98M | 11.22M | 11.98M | 8.18M | 8.25M | 9.27M | 6.91M | 6.56M | 9.22M | 6.97M |
Deferred Revenue | 50.87M | n/a | 41.58M | n/a | 31.65M | 10.87M | 86.3M | 10.47M | 9.95M | 15.48M | n/a | n/a | n/a | n/a | -40.63M | n/a | 665K | n/a |
Short-Term Debt | n/a | 984K | n/a | n/a | 44K | n/a | 151K | 225K | 297K | 575K | 1.14M | 1.71M | 2.26M | 2.26M | 526K | 1.05M | 1.56M | 2.07M |
Other Current Liabilities | 33.16M | 114.14M | 44M | 79.2M | 54.3M | 14.52M | 28.85M | 86.29M | 71.91M | 32.52M | 42.63M | 23.14M | 27.41M | 38.48M | 25.73M | 20.57M | 25.33M | 13.71M |
Total Current Liabilities | 144.66M | 143.07M | 140.77M | 126.22M | 100.75M | 97.2M | 104.5M | 121.87M | 93.06M | 25.22M | 81.59M | 53.07M | 54.04M | 57.24M | 6.91M | 44.76M | 45.4M | 40.6M |
Long-Term Debt | n/a | 5.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 15.68M | 14.25M | 14.08M | 12.85M | 11.94M | 10.87M | 10.31M | 10.47M | 9.95M | 9.4M | 9.1M | 6.82M | 4.98M | 2.52M | 409K | 413K | 403K | 995K |
Total Long-Term Liabilities | 21.27M | 20.1M | 20.19M | 19.21M | 17.56M | 10.87M | 10.31M | 10.47M | 9.95M | 63.05M | 9.1M | 6.82M | 4.98M | 3.07M | 41.04M | 413K | 403K | 995K |
Total Liabilities | 165.93M | 163.17M | 160.96M | 145.42M | 118.31M | 108.07M | 114.81M | 132.34M | 103.01M | 88.26M | 81.59M | 59.89M | 54.04M | 60.31M | 47.95M | 45.17M | 45.8M | 41.6M |
Total Debt | 6.61M | 6.83M | 6.94M | 6.79M | 5.67M | 76K | 151K | 225K | 297K | 575K | 1.14M | 1.71M | 2.26M | 2.82M | 526K | 1.05M | 1.56M | 2.07M |
Common Stock | 138K | 137K | 136K | 135K | 134K | 133K | 133K | 133K | 132K | 131K | 131K | 130K | 128K | 128K | 127K | 126K | 125K | 124K |
Retained Earnings | 599.43M | 564.28M | 543.74M | 512.99M | 465.78M | 430.29M | 402.53M | 371.17M | 339.79M | 312.26M | 296.39M | 279.79M | 245.18M | 217.76M | 194.97M | 162.91M | 132.44M | 105.92M |
Comprehensive Income | 2.29M | 692K | -217K | 1.57M | 84K | 258K | 609K | -234K | 45K | -153K | -869K | -2.38M | -2.14M | -1.35M | -227K | 115K | 215K | 249K |
Shareholders Equity | 635.79M | 683.28M | 679.59M | 638.84M | 596.24M | 547.86M | 506.7M | 461.68M | 421.61M | 529.58M | 501.84M | 473.36M | 442.33M | 407.81M | 375.81M | 540.23M | 522.67M | 510.8M |
Total Investments | 412.26M | 232.94M | 475.5M | 410.36M | 363.88M | 301.29M | 289.85M | 303.05M | 190.88M | 165.12M | 370.29M | 350.91M | 346.63M | 306.23M | 258.19M | 400.49M | 376.21M | 402.41M |